| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Diabetes, Endocrinology, and Nutrition (J.M.F.-R., F.O., J.M.M.-N., W.R.). Institut dInvestigació Biomédica de Girona, CIBER Fisiopatología de la Obesidad y Nutrición CB06/03/010, 17007 Girona, Catalonia, Spain; Studies, Research, and Sports Medicine Center (M.I., E.G., C.M., J.I.), Government of Navarra, 31005 Pamplona, Spain; Department of Endocrinology (J.G.-A., G.F., J.S.), University of Navarra, and CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 31008 Pamplona, Spain; Department of Radiology (F.I.), Clinic of San Miguel, Pamplona-Navarra, Spain; and Department of Endocrinology (L.F.), Hospital of Navarra, 31005 Pamplona-Navarra, Spain
Address all correspondence and requests for reprints to: Jose Manuel Fernandez-Real, M.D., Ph.D., Unit of Diabetes, Endocrinology, and Nutrition, Hospital de Girona "Dr. Josep Trueta", Ctra. França s/n, E-17007 Girona, Catalonia, Spain. E-mail: uden.jmfernandezreal{at}htrueta.scs.es.
Context: Bone has recently been described as exhibiting properties of an endocrine organ by producing osteocalcin that increases insulin sensitivity and secretion in animal models.
Objective and Design: We aimed to evaluate circulating osteocalcin in association with insulin sensitivity and insulin secretion in three different studies in nondiabetic subjects: one cross-sectional study in 149 men (using minimal model), and two longitudinal studies in two independent groups (one formed by 26 women, and the other by 9 men and 11 women), after a mean of 7.3 and 16.8% weight loss, and after a mean of 8.7% weight loss plus regular exercise.
Results: In the cross-sectional study, circulating osteocalcin was associated with insulin sensitivity, mainly in lean subjects, and with insulin secretion (only in lean subjects). A mean of 16.8%, but not 7.3% weight loss, led to significant increases in circulating osteocalcin. However, a mean of 8.7% weight loss plus regular exercise led to the more pronounced effects on the serum osteocalcin concentration, which increased in parallel to reduced visceral fat mass, unchanged thigh muscle mass, and increased leg strength and force. The postintervention serum levels of osteocalcin were associated with both insulin sensitivity (r = 0.49; P = 0.03) and fasting triglycerides (r = –0.54; P = 0.01). The change in visceral fat was the parameter that best predicted the change in serum osteocalcin, once age, body mass index, and insulin sensitivity changes were controlled for (P = 0.002).
Conclusion: Circulating osteocalcin could mediate the role of bone as an endocrine organ in humans.
This article has been cited by other articles:
![]() |
M. Zhou, X. Ma, H. Li, X. Pan, J. Tang, Y. Gao, X. Hou, H. Lu, Y. Bao, and W. Jia Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals Eur. J. Endocrinol., November 1, 2009; 161(5): 723 - 729. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sucunza, M. J. Barahona, E. Resmini, J.-M. Fernandez-Real, W. Ricart, J. Farrerons, J. Rodriguez Espinosa, A.-M. Marin, T. Puig, and S. M. Webb A Link between Bone Mineral Density and Serum Adiponectin and Visfatin Levels in Acromegaly J. Clin. Endocrinol. Metab., October 1, 2009; 94(10): 3889 - 3896. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Guadalupe-Grau, J. Perez-Gomez, H. Olmedillas, J. Chavarren, C. Dorado, A. Santana, J. A. Serrano-Sanchez, and J. A. L. Calbet Strength training combined with plyometric jumps in adults: sex differences in fat-bone axis adaptations J Appl Physiol, April 1, 2009; 106(4): 1100 - 1111. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |